Catalyst Wire Dossier Catalyst Wire Dossier

Aspart 30

insulin aspart
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aspart 30, covering 2018-11-14 to 2018-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM [Phase 4]

See pricing